Hidetada Ogata Selected Research

Diabetes Mellitus

10/2012

Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidetada Ogata Research Topics

Disease

3	Glucose Intolerance 01/2016 - 10/2012
2	Graves Disease (Basedow Disease) 04/2021 - 01/2016
2	Weight Gain 01/2018 - 11/2017
2	Body Weight (Weight, Body) 01/2018 - 11/2017
2	Obesity 11/2017 - 10/2012
1	Thyroiditis 04/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Thyroid Diseases (Thyroid Disease) 01/2018
1	Hyperglycemia 01/2015
1	Diabetes Mellitus 10/2012
1	Insulin Resistance 10/2012

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2015
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2017 - 10/2012
2	CarbohydratesIBA 01/2018 - 11/2017
2	Sucrose (Saccharose)IBA 11/2017 - 10/2012
1	Amino Acids FDA Link 04/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2021
1	gastric inhibitory polypeptide receptorIBA 01/2018
1	AcidsIBA 01/2018
1	Carboxy-LyasesIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Starch (Cornstarch)IBA 11/2017
1	FructoseIBA 11/2017
1	Hormones (Hormone)IBA 11/2017
1	fibroblast growth factor 21IBA 11/2017
1	AutoantibodiesIBA 01/2016
1	Thyroglobulin FDA Link 01/2016
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2015
1	GlucokinaseIBA 10/2012

Therapy/Procedure

1	Therapeutics 01/2016